Back

Efficacy of sodium-glucose cotransporter - 2 inhibitors in patients after implantation of the left ventricular assist device

20 May 2023 (12:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Chronic Heart Failure - Ventricular Assist Devices Ventricular Assist Devices HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Katarzyna Byczkowska

National Institute of Cardiology, Warsaw (Poland)

6 More presentations in this session

Presentation thumbnail
LVAD as bridge to recovery in alcoholic cardiomyopathy: a single center experience
Doctor F. Valente (Brussels, BE)
Abstract Slides
Presentation thumbnail
Predictive role of pre- and post-operative soluble ST2 in heart failure patients on left ventricular assist device (LVAD) support
Ms L. Numan (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Clinical, remodeling and hemodynamic effects of renin-angiotensin-aldosterone system inhibitors among patients on left ventricular assist device support
Doctor G. Gallone (Turin, IT)
Abstract Slides
Presentation thumbnail
Circadian rhythms in pump parameters of patients on left ventricular assist device (LVAD) support
Ms L. Numan (Utrecht, NL)
Abstract Slides
Presentation thumbnail
LVAD improves survival in Duchenne muscular dystrophy population
Doctor R. Adorisio (Rome, IT)
Abstract Slides

Access the full session

Session thumbnail
Chronic Heart Failure - Ventricular Assist Devices

The Event

Event poster

Heart Failure 2023

20 May 2023 12:00 CET
You may be interested in
thumbnail
Congress Session
Navigating through heart failure device therapies
thumbnail
Congress Session
Which device might help your HFpEF patient?
thumbnail
Congress Session
Devices in acute heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources